Omlor Georg W, Kleinschmidt Kerstin, Gantz Simone, Speicher Anja, Guehring Thorsten, Richter Wiltrud
a Center for Orthopedics, Trauma Surgery and Spinal Cord Injury , Heidelberg University Hospital ;
b Research Center for Experimental Orthopedics , Heidelberg University Hospital ;
Acta Orthop. 2016 Aug;87(4):425-31. doi: 10.1080/17453674.2016.1198200. Epub 2016 Jun 27.
Background and purpose - Delayed bone healing with non-union is a common problem. Further options to increase bone healing together with surgery are needed. We therefore evaluated a 1-dose single application of erythropoietin (EPO), applied either locally to the defect or systemically during surgery, in a critical-size rabbit long-bone defect. Material and methods - 19 New Zealand White rabbits received a 15-mm defect in the radius diaphysis. An absorbable gelatin sponge was soaked with saline (control group and systemic treatment group) or EPO (local treatment group) and implanted into the gap. The systemic treatment group received EPO subcutaneously. In vivo micro-CT analysis was performed 4, 8, and 12 weeks postoperatively. Vascularization was evaluated histologically. Results - Semiquantitative histomorphometric and radiological evaluation showed increased bone formation (2.3- to 2.5-fold) in both treatment groups after 12 weeks compared to the controls. Quantitative determination of bone volume and tissue volume showed superior bone healing after EPO treatment at all follow-up time points, with the highest values after 12 weeks in locally treated animals (3.0- to 3.4-fold). More vascularization was found in both EPO treatment groups. Interpretation - Initial single dosing with EPO was sufficient to increase bone healing substantially after 12 weeks of follow-up. Local application inside the defect was most effective, and it can be administered directly during surgery. Apart from effects on ossification, systemic and local EPO treatment leads to increased callus vascularization.
背景与目的——延迟骨愈合伴骨不连是一个常见问题。除手术外,还需要更多促进骨愈合的方法。因此,我们在兔临界大小的长骨缺损模型中,评估了单次应用促红细胞生成素(EPO),分别采用局部缺损处应用或手术期间全身应用的方式。材料与方法——19只新西兰白兔的桡骨干中段制造15毫米的缺损。将可吸收明胶海绵用生理盐水(对照组和全身治疗组)或EPO(局部治疗组)浸泡后植入骨缺损处。全身治疗组皮下注射EPO。术后4周、8周和12周进行体内微型CT分析。通过组织学评估血管生成情况。结果——半定量组织形态计量学和影像学评估显示,与对照组相比,两个治疗组在12周后骨形成增加(2.3至2.5倍)。骨体积和组织体积的定量测定显示,在所有随访时间点,EPO治疗后的骨愈合情况更佳,局部治疗组在12周时的值最高(3.0至3.4倍)。两个EPO治疗组均发现更多的血管生成。解读——随访12周后,初始单次给予EPO足以显著促进骨愈合。在缺损处局部应用最为有效,且可在手术期间直接给药。除了对骨化的影响外,全身和局部应用EPO治疗均可增加骨痂血管生成。